Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sugammadex and Neostigmine dose finding study for reversal of residual neuromuscular blockade
2008-008239-27Phase 4Completed
- Sponsor
- Technical University of Munich
- Start
- Dec 2008
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4 trial of Sugammadex and neostigmine in neuromuscular block (NMB), sponsored by Technical University of Munich. Started Dec 2008; status: completed.
02
Drugs
Sugammadexneostigmine
03
Conditions
neuromuscular block (NMB)
Beyond the preview
Go deeper on 2008-008239-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-008239-27.